5 Key Takeaways

• 1

  SLT is recommended as a first-line therapy for open-angle glaucoma due to its safety and potential for better long-term disease control.

• 2

  The LiGHT trial studies support the use of SLT over traditional treatments for managing open-angle glaucoma and ocular hypertension.

• 3

  Laser Peripheral Iridotomy (LPI) is used for managing closed-angle glaucoma but is performed less frequently than SLT.

• 4

  Prophylactic LPIs for primary angle closure suspects are not recommended, with phacoemulsification lens extraction as a preferred alternative.

• 5

  Open discussions with patients about treatment options enhance their participation in care and management of glaucoma.